Vox Markets Interview with Avacta CEO Alastair Smith
Episode 1609, Sep 19, 2023, 02:42 PM
Following today’s “stunning” safety & efficacy data wrt Avacta's AVA6000 phase 1a clinical trial, I was delighted to catchup again with CEO Alastair Smith, who took me through the hugely significant news.